13F HOLDINGS REPORT
Lion Point Capital, LP
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001013594-26-000252
Total Value
$19.3M
Positions
39
Other Managers
0
Confidential Omitted
No
Holdings (39)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MILESTONE PHARMACEUTICALS IN | MIST | 755,000 | $1.5M | 7.89% |
| 2 | PRAXIS PRECISION MEDICINES I | PRAX | 4,450 | $1.3M | 6.79% |
| 3 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 67,500 | $889,650 | 4.60% |
| 4 | FENNEC PHARMACEUTICALS INC | FENC | 112,434 | $865,742 | 4.48% |
| 5 | JASPER THERAPEUTICS INC | JSPRW | 465,000 | $850,950 | 4.40% |
| 6 | BENITEC BIOPHARMA INC | BNTC | 62,000 | $835,140 | 4.32% |
| 7 | ROYALTY PHARMA PLC | RPRX | 21,400 | $826,896 | 4.28% |
| 8 | GERON CORP | GERN | 578,000 | $762,960 | 3.95% |
| 9 | SYNDAX PHARMACEUTICALS INC | SNDX | 36,000 | $756,360 | 3.91% |
| 10 | ARDELYX INC | ARDX | 128,650 | $750,030 | 3.88% |
| 11 | CUE BIOPHARMA INC | CUE | 2,202,854 | $672,752 | 3.48% |
| 12 | DISC MEDICINE INC | IRON | 8,100 | $643,221 | 3.33% |
| 13 | SAREPTA THERAPEUTICS INC | SRPT | 28,500 | $613,320 | 3.17% |
| 14 | BIOHAVEN LTD | BHVN | 51,700 | $583,693 | 3.02% |
| 15 | HUMACYTE INC | HUMAW | 500,000 | $480,250 | 2.49% |
| 16 | KURA ONCOLOGY INC | KURA | 46,000 | $477,940 | 2.47% |
| 17 | SERES THERAPEUTICS INC | MCRB | 31,570 | $469,762 | 2.43% |
| 18 | COMPASS PATHWAYS PLC | CMPS | 58,000 | $400,200 | 2.07% |
| 19 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 42,000 | $391,440 | 2.03% |
| 20 | REGENXBIO INC | RGNX | 26,600 | $383,040 | 1.98% |
| 21 | BRIDGEBIO PHARMA INC | BBIO | 5,000 | $382,450 | 1.98% |
| 22 | MINERALYS THERAPEUTICS INC | MLYS | 10,500 | $381,045 | 1.97% |
| 23 | VENTYX BIOSCIENCES INC | 92332V107 | 41,500 | $374,745 | 1.94% |
| 24 | LANTHEUS HLDGS INC | LNTH | 5,500 | $366,025 | 1.89% |
| 25 | DYNE THERAPEUTICS INC | DYN | 18,000 | $352,080 | 1.82% |
| 26 | UNIQURE NV | QURE | 14,700 | $351,771 | 1.82% |
| 27 | PACIRA PHARMACEUTICALS INC | PCRX | 13,500 | $349,380 | 1.81% |
| 28 | VIATRIS INC | VTRS | 27,700 | $344,865 | 1.78% |
| 29 | AZENTA INC | AZTA | 9,700 | $322,622 | 1.67% |
| 30 | ROCKET PHARMACEUTICALS INC | RCKTW | 86,000 | $301,860 | 1.56% |
| 31 | JANUX THERAPEUTICS INC | JANX | 19,000 | $262,200 | 1.36% |
| 32 | EDGEWISE THERAPEUTICS INC | EWTX | 9,100 | $225,817 | 1.17% |
| 33 | INNOVIVA INC | INVA | 8,200 | $163,918 | 0.85% |
| 34 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 5,250 | $152,460 | 0.79% |
| 35 | INNATE PHARMA S A | IPHYF | 81,151 | $142,014 | 0.73% |
| 36 | MINERVA NEUROSCIENCES INC | NERV | 35,000 | $140,700 | 0.73% |
| 37 | GH RESEARCH PLC | GHRS | 10,200 | $129,540 | 0.67% |
| 38 | SPRUCE BIOSCIENCES INC | SPRB | 1,000 | $87,110 | 0.45% |
| 39 | MERSANA THERAPEUTICS INC | 59045L205 | 100 | $2,893 | 0.01% |